Comparison of HIT Tests in Patients with COVID-19 and Thrombocytopenia

Esra’a Abudouleh1 Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi ArabiaView further author information

Ahmad Alhamshari2 College of Medicine, Alfaisal University, Riyadh, Saudi ArabiaView further author information

Ahmed A Al-Qahtani3 Department of Infection and Immunity, Research Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia;4 Department of Microbiology and Immunology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia

https://orcid.org/0000-0003-4584-5739 View further author information

Amelita Aguilos5 Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi ArabiaView further author information

Tarek Owaidah5 Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi ArabiaCorrespondence[email protected]
View further author information

References

Schulman S, Hu Y, Konstantinides S. Venous thromboembolism in COVID-19. J Thromb Haemost. 2020;120:1642–1653. doi:10.1055/s-0040-1718532
Web of Science ®Google Scholar
Lingamaneni P, Gonakoti S, Moturi K, et al. Heparin-induced thrombocytopenia in COVID-19. J Investig Med High Impact Case Rep. 2020;8:2324709620944091. doi:10.1177/2324709620944091
Web of Science ®Google Scholar
Uaprasert N, Tangcheewinsirikul N, Rojnuckarin P, et al. Heparin-induced thrombocytopenia in patients with COVID-19: a systematic review and meta-analysis. Blood Adv. 2021;5:4521–4534. doi:10.1182/bloodadvances.2021005314
PubMed Web of Science ®Google Scholar
Arepally GM. Heparin-induced thrombocytopenia. Blood. 2017;129:2864–2872. doi:10.1182/blood-2016-11-709873
PubMed Web of Science ®Google Scholar
Sachs UJ, von Hesberg J, Santoso S, Bein G, Bakchoul T. Evaluation of a new nanoparticle-based lateral-flow immunoassay for the exclusion of heparin-induced thrombocytopenia (HIT). Thromb Haemost. 2011;106(6):1197–1202. doi:10.1160/TH11-06-0390
PubMed Web of Science ®Google Scholar
Cuker A, Gimotty PA, Crowther MA, et al. Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood. 2012;120:4160–4167. doi:10.1182/blood-2012-07-443051
PubMed Web of Science ®Google Scholar
Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction score. J Thromb Haemost. 2010;8:2450–2457. doi:10.1111/j.1538-7836.2010.04044.x
PubMed Web of Science ®Google Scholar

Comparison of HIT Tests in Patients with COVID-19 and Thrombocytopenia

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Comparison of HIT Tests in Patients with COVID-19 and Thrombocytopenia

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date